Newly listed stock N Lianya opened 285.71% higher; public information shows that the company is mainly engaged in the research, development, production and sales of complex drug formulations. Its products include two major categories of high-end gene

2026-10-15

Newly listed stock N Lianya opened 285.71% higher; public information shows that the company is mainly engaged in the research, development, production and sales of complex drug formulations. Its products include two major categories of high-end generic drugs, including different types of sustained-release and controlled-release formulations and low-dose drug formulations, which are mainly used in the fields of hypertension, coronary heart disease, diabetes, schizophrenia, female contraception and health.